GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.360
-0.020 (-0.84%)
At close: Apr 28, 2026, 4:00 PM EDT
2.280
-0.080 (-3.39%)
Pre-market: Apr 29, 2026, 8:49 AM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $3.41 million as of April 29, 2026. Its market cap has increased by 252.54% in one year.
Market Cap
3.41M
Enterprise Value
-4.75M
1-Year Change
252.54%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.29M to $3.41M, a decrease of -86.51%. That is a compound annual growth rate of -48.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3.41M | 36.53% |
| Dec 31, 2025 | 2.50M | -66.25% |
| Dec 31, 2024 | 7.40M | 326.73% |
| Dec 29, 2023 | 1.73M | -93.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alzamend Neuro | 4.11M |
| Galmed Pharmaceuticals | 4.11M |
| Jaguar Health | 3.93M |
| Matinas BioPharma Holdings | 3.91M |
| Azitra | 3.63M |
| Ensysce Biosciences | 3.55M |
| Artelo Biosciences | 3.54M |
| GeoVax Labs | 3.21M |